GSH-responsive nanomedicine holds significant promise when used in combination with other therapeutic modalities
Kane SP, Murray-Lyon IM, Paradinas FJ, Johnson PJ, Williams R, Orr HA, et al
Creatine phosphate provides the rapidly available ATP buffer that supports the high-intensity exercise most likely to upregulate endogenous MOTS-c
The GLP-1 plotter and tracking tools from SeekPeptides will continue to evolve alongside these treatments, helping researchers make sense of an increasingly complex landscape
(2015) described the development of angiotensin IV analogs including Dihexa and their HGF/c-Met potentiation mechanism (PMID: 25455861) Expression of Concern: The landmark 2012 paper describing Dihexa's cognitive effects received an expression of concern from the journal (PMID: 34551989), citing data integrity issues including questioned Western blot images Retraction: A follow-up paper from the same research group was retracted (PMID: 40312093), further undermining the evidence base for Dihexa's reported effects No Human Studies: No clinical trials, pharmacokinetic studies, or safety assessments have been conducted in humans Limited Independent Replication: The core claims about Dihexa's cognitive-enhancing effects have not been independently replicated by groups outside the original laboratory The Evidence Gap: This comparison starkly illustrates the difference between a compound with decades of clinical validation (Cerebrolysin) and one with provocative preclinical data undermined by integrity concerns (Dihexa)
We would recommend seeing your GP for further information
